Bio-Rad Laboratories, Inc.

US$381.57As of Sun 8 Nov 2026, 12:00 UTC
NYSE:BIOHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 9.19%
Div yield —
ROE 14.27%
Medical Devices
Beta (5Y) 1.06
PE TTM 10.05
TSR TTM 19.41%
Mkt cap US$10.26B
ROIC 2.67%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$464
21.59%
(59.52%)
Hold 2|8|1|11|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
5.32
5.71
6.17
6.68
7.68%
5.47%
13.00%
20.21%
Revenue$M
532.2
548.2
545.4
563.5
3.20%
0.80%
3.25%
9.87%
Peers (US$10.26B)
Cap (US$)
PE
10.16B
23.90x
9.412B
17.50x
9.363B
—
11.76B
24.51x
Capital
TTM
5Y
10Y
Leveragex
5.535
0.090
0.078
EBIT/Intx
2.058
0.305
0.270
Own earn%
122.69
69.21
66.49
Sh yield%
19.90
36.86
40.46
Owners
Insiders/Inst%
8.58
79.44
Short interest%
1.13
SBC / revenue%
2.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
28–35
$1 testx
0.0
Incr. ROIC%
13